BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38663815)

  • 1. Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma.
    Tang M; Charbit AR; Johansson MW; Jarjour NN; Denlinger LC; Raymond WW; Peters MC; Dunican EM; Castro M; Sumino K; Erzurum SC; Comhair SA; Moore WC; Levy BD; Israel E; Phipatanakul W; Phillips BR; Mauger DT; Bleecker ER; Wenzel SE; Fajt ML; Woodruff PG; Hastie AT; Fahy JV;
    J Allergy Clin Immunol; 2024 Apr; ():. PubMed ID: 38663815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia.
    Nair P; Ochkur SI; Protheroe C; Radford K; Efthimiadis A; Lee NA; Lee JJ
    Allergy; 2013 Sep; 68(9):1177-84. PubMed ID: 23931643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition.
    Kobayashi Y; Chu HH; Bui DV; Yun Y; Nguyen LM; Mitani A; Suzuki K; Asako M; Kanda A; Iwai H
    Cells; 2023 Nov; 12(23):. PubMed ID: 38067174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal and pharyngeal eosinophil peroxidase levels in adults with poorly controlled asthma correlate with sputum eosinophilia.
    Rank MA; Ochkur SI; Lewis JC; Teaford HG; Wesselius LJ; Helmers RA; Lee NA; Nair P; Lee JJ
    Allergy; 2016 Apr; 71(4):567-70. PubMed ID: 26645423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma.
    Klein DK; Silberbrandt A; Frøssing L; Hvidtfeldt M; von Bülow A; Nair P; Mukherjee M; Porsbjerg C
    Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35236724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
    Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
    Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 innate lymphoid cells: A novel biomarker of eosinophilic airway inflammation in patients with mild to moderate asthma.
    Liu T; Wu J; Zhao J; Wang J; Zhang Y; Liu L; Cao L; Liu Y; Dong L
    Respir Med; 2015 Nov; 109(11):1391-6. PubMed ID: 26459159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
    Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
    Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
    Kulkarni NS; Hollins F; Sutcliffe A; Saunders R; Shah S; Siddiqui S; Gupta S; Haldar P; Green R; Pavord I; Wardlaw A; Brightling CE
    J Allergy Clin Immunol; 2010 Jul; 126(1):61-9.e3. PubMed ID: 20639010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
    Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
    J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum Type 2 Markers Could Predict Remission in Severe Asthma Treated With Anti-IL-5.
    Moermans C; Brion C; Bock G; Graff S; Gerday S; Nekoee H; Poulet C; Bricmont N; Henket M; Paulus V; Guissard F; Louis R; Schleich F
    Chest; 2023 Jun; 163(6):1368-1379. PubMed ID: 36740095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma.
    Katz LE; Gleich GJ; Hartley BF; Yancey SW; Ortega HG
    Ann Am Thorac Soc; 2014 May; 11(4):531-6. PubMed ID: 24606022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.
    Mukherjee M; Aleman Paramo F; Kjarsgaard M; Salter B; Nair G; LaVigne N; Radford K; Sehmi R; Nair P
    Am J Respir Crit Care Med; 2018 Jan; 197(1):38-46. PubMed ID: 28915080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
    Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
    Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum autoantibodies in patients with severe eosinophilic asthma.
    Mukherjee M; Bulir DC; Radford K; Kjarsgaard M; Huang CM; Jacobsen EA; Ochkur SI; Catuneanu A; Lamothe-Kipnes H; Mahony J; Lee JJ; Lacy P; Nair PK
    J Allergy Clin Immunol; 2018 Apr; 141(4):1269-1279. PubMed ID: 28751233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An eosinophil peroxidase activity assay accurately predicts eosinophilic chronic rhinosinusitis.
    Smith KA; Gill AS; Pollard CE; Sumsion JS; Saffari H; Ashby S; Witt BL; Shipman PA; Gabrielsen DA; Yim MT; Levy JM; Oakley GM; Orlandi RR; Gleich GJ; Alt JA; Pulsipher A
    J Allergy Clin Immunol; 2023 Aug; 152(2):400-407. PubMed ID: 37148919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-assessed large airway involvement and lung function decline in eosinophilic asthma: The association between induced sputum eosinophil differential counts and airway remodeling.
    Inoue H; Ito I; Niimi A; Matsumoto H; Matsuoka H; Jinnai M; Takeda T; Oguma T; Otsuka K; Nakaji H; Tajiri T; Iwata T; Nagasaki T; Kanemitsu Y; Mishima M
    J Asthma; 2016 Nov; 53(9):914-21. PubMed ID: 27115448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective longitudinal study of urinary eosinophil protein X in children with asthma and chronic cough.
    Labbé A; Aublet-Cuvelier B; Jouaville L; Beaugeon G; Fiani L; Petit I; Ouchchane L; Doly M
    Pediatr Pulmonol; 2001 May; 31(5):354-62. PubMed ID: 11340681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.